191 related articles for article (PubMed ID: 35912197)
81. Novel nomograms to predict lymph node metastasis and distant metastasis in resected patients with early-stage non-small cell lung cancer.
Tian Y; He Y; Li X; Liu X
Ann Palliat Med; 2021 Mar; 10(3):2548-2566. PubMed ID: 33691451
[TBL] [Abstract][Full Text] [Related]
82. Establishment of a Dynamic Nomogram for Predicting the Risk of Lymph Node Metastasis in T1 Stage Colorectal Cancer.
Liu Z; Huang C; Tian H; Liu Y; Huang Y; Zhu Z
Front Surg; 2022; 9():845666. PubMed ID: 35388361
[TBL] [Abstract][Full Text] [Related]
83. Micropapillary: A component more likely to harbour heterogeneous EGFR mutations in lung adenocarcinomas.
Cai YR; Dong YJ; Wu HB; Liu ZC; Zhou LJ; Su D; Chen XJ; Zhang L; Zhao YL
Sci Rep; 2016 Apr; 6():23755. PubMed ID: 27046167
[TBL] [Abstract][Full Text] [Related]
84. Occult lymph node metastases increase locoregional recurrence in differentiated thyroid carcinoma.
Patron V; Hitier M; Bedfert C; Le Clech G; Jégoux F
Ann Otol Rhinol Laryngol; 2012 May; 121(5):283-90. PubMed ID: 22724272
[TBL] [Abstract][Full Text] [Related]
85. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
[TBL] [Abstract][Full Text] [Related]
86. Correlation between EML4-ALK, EGFR and clinicopathological features based on IASLC/ATS/ERS classification of lung adenocarcinoma.
Wang H; Zhang W; Wang K; Li X
Medicine (Baltimore); 2018 Jun; 97(26):e11116. PubMed ID: 29952952
[TBL] [Abstract][Full Text] [Related]
87. A new approach to predict lymph node metastasis in solid lung adenocarcinoma: a radiomics nomogram.
Yang X; Pan X; Liu H; Gao D; He J; Liang W; Guan Y
J Thorac Dis; 2018 Apr; 10(Suppl 7):S807-S819. PubMed ID: 29780627
[TBL] [Abstract][Full Text] [Related]
88. [A novel nomogram for individualized preoperative prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma].
Ma WH; Lei ZQ; Yu QS; Xiao QR; Tang HL; Si AF; Yang PH; Cheng ZJ
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):363-371. PubMed ID: 35272428
[No Abstract] [Full Text] [Related]
89. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
[No Abstract] [Full Text] [Related]
90. Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas.
Guerrera F; Renaud S; Tabbó F; Voegeli' AC; Filosso PL; Legrain M; Boita M; Schaeffer M; Beau-Faller M; Ruffini E; Falcoz PE; Inghirami G; Oliaro A; Massard G
Eur J Cardiothorac Surg; 2017 Apr; 51(4):680-688. PubMed ID: 28329143
[TBL] [Abstract][Full Text] [Related]
91. Prognostic impact of micropapillary component in patients with node-negative subcentimeter lung adenocarcinoma: A Chinese cohort study.
Yao J; Zhu E; Li M; Liu J; Zhang L; Ke H; Su H; Xie H; Xu G; Zhu L; Fan J; Chen C;
Thorac Cancer; 2020 Dec; 11(12):3566-3575. PubMed ID: 33058505
[TBL] [Abstract][Full Text] [Related]
92. Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study.
Kanzaki R; Higashiyama M; Fujiwara A; Tokunaga T; Maeda J; Okami J; Kozuka T; Hosoki T; Hasegawa Y; Takami M; Tomita Y; Kodama K
Lung Cancer; 2011 Mar; 71(3):333-7. PubMed ID: 20619479
[TBL] [Abstract][Full Text] [Related]
93. [Validation of prognostic value of pathological staging in pathological stage Ⅰ lung adenocarcinoma].
Zhang H; Sun FH; Chen ZC; Wang Q
Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):580-586. PubMed ID: 35658346
[No Abstract] [Full Text] [Related]
94. Nomogram to predict lymph node metastasis in patients with early gastric cancer: a useful clinical tool to reduce gastrectomy after endoscopic resection.
Kim SM; Min BH; Ahn JH; Jung SH; An JY; Choi MG; Sohn TS; Bae JM; Kim S; Lee H; Lee JH; Kim YW; Ryu KW; Kim JJ; Lee JH
Endoscopy; 2020 Jun; 52(6):435-443. PubMed ID: 32162286
[TBL] [Abstract][Full Text] [Related]
95. Clinicopathological and computed tomography features associated with recurrence-free survival of patients with small-sized peripheral invasive lung adenocarcinoma after sublobectomy.
Huo J; Luo T; Lv F; Li Q
Quant Imaging Med Surg; 2023 Dec; 13(12):8144-8156. PubMed ID: 38106273
[TBL] [Abstract][Full Text] [Related]
96. Molecular alterations in a new cell line (KU-Lu-MPPt3) established from a human lung adenocarcinoma with a micropapillary pattern.
Matsuo Y; Shiomi K; Sonoda D; Mikubo M; Naito M; Matsui Y; Yoshida T; Satoh Y
J Cancer Res Clin Oncol; 2018 Jan; 144(1):75-87. PubMed ID: 29090354
[TBL] [Abstract][Full Text] [Related]
97. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
[TBL] [Abstract][Full Text] [Related]
98. Novel perspective to evaluate the safety of segmentectomy: clinical significance of lobar and segmental lymph node metastasis in cT1N0M0 lung adenocarcinoma.
Xiao F; Yu Q; Zhang Z; Liu D; Guo Y; Liang C; Wang B; Sun H
Eur J Cardiothorac Surg; 2018 Jan; 53(1):228-234. PubMed ID: 28950357
[TBL] [Abstract][Full Text] [Related]
99. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546
[TBL] [Abstract][Full Text] [Related]
100. A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer.
Zhang Z; Xie S; Cai W; Hong ZN; Yang C; Lin Y; Zhu J; Lin Z; Christoph DC; Bohnenberger H; Kepka L; Brueckl WM; Van Houtte P; Kang M; Lin J
Transl Lung Cancer Res; 2022 Jan; 11(1):75-86. PubMed ID: 35242629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
